Related Experiment Video
Updated: May 10, 2025
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Effective Spesolimab Treatment for Generalized Pustular Psoriasis Masquerading as Acute Generalized Exanthematous
Kazuyoshi Iijima1, Yuko Akiyama1, Itsumi Mizukawa1
1Department of Dermatology, Teikyo Mizonokuchi Hospital, Kanagawa, JPN.
Abstract:
Generalized pustular psoriasis (GPP) is a rare and severe variant of psoriasis, often posing diagnostic challenges due to its clinical overlap with acute generalized exanthematous pustulosis (AGEP), a severe drug-induced hypersensitivity reaction. Spesolimab, a monoclonal antibody targeting the interleukin 36 (IL-36) receptor, provides rapid symptom relief for GPP flares, but real-world data remain limited. We report a case of GPP complicated by overlapping features with AGEP, highlighting the importance of precise diagnosis and the efficacy of spesolimab.
Related Concept Videos
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...